Label Changes for:

Viracept (nelfinavir mesylate) Oral Powder, 50 mg/gViracept (nelfinavir mesylate) Tablets, 250 mgViracept (nelfinavir mesylate) Tablets, 625 mg

May 2013

Changes have been made to the PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

 

May 2013

7 DRUG INTERACTIONS

7.3 Established and Potentially Significant Drug Interactions
  • added.........omeprazole: Omeprazole decreases the plasma concentrations of nelfinavir.Concomitant use of proton pump inhibitors and VIRACEPT may lead to a loss of virologic response and development of resistance

 

April 2012

 

CONTRAINDICATIONS

Table 3
Hide
(web2)